abstract |
The present invention relates to a composition for intracellular delivery comprising a peptide derived from an adenovirus protein VI and a pharmaceutical composition for anticancer comprising the same. According to the present invention, when the peptide or peptide-polymer conjugate of the present invention is used, the intracellular delivery efficiency of a nucleic acid, a peptide, a polypeptide, an antibody, a chemical substance or a virus is improved. Accordingly, the peptide or peptide-polymer complex of the present invention can be usefully used as an intracellular carrier of various therapeutic agents. |